Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Pleural mesothelioma malignant

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study of Efgartigimod for Adults with Thyroid Eye Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Acne

Not recruiting

Investigational

Study of N-Acetyl-GED-0507-34-LEVO 5% gel applied daily for 12 weeks in patients with acne vulgaris

Investigational

Italy

Participants:0–17 years · 18–64 years
Substances:(S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid

Contact Research Centre

Acne

Not recruiting

InvestigationalNo placebo

Title: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:(S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lutikizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Neovascular age-related macular degeneration

Not recruiting

Registered drugNo placebo

Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Find therapies in clinical trials near you – page 13

191 trials match your criteria

Pleural mesothelioma malignant

Study of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma

Hidradenitis

Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Hormone receptor positive HER2 negative breast cancer

Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

Endocrine ophthalmopathy

Study of Efgartigimod for Adults with Thyroid Eye Disease

Malignant melanoma

Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

Acne

Study of N-Acetyl-GED-0507-34-LEVO 5% gel applied daily for 12 weeks in patients with acne vulgaris

Acne

Title: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris

Hidradenitis

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Non-small cell lung cancer

Study on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer

Breast cancer

Study on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer

Neovascular age-related macular degeneration

Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

Hidradenitis

Study on Amlitelimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.